-+ 0.00%
-+ 0.00%
-+ 0.00%

Ultragenyx Pharmaceutical Exec Says U.S. Per Patient Wholesale Acquisition Cost For Fayuvi Is Set At $3.95M

Benzinga·09/17/2026 21:59:53
Listen to the news

https://event.choruscall.com/mediaframe/webcast.html?webcastid=1t78iDYA